{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:49:08Z","timestamp":1740163748040,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 CA195558"],"award-info":[{"award-number":["RO1 CA195558"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We have been studying the role of Hexamethylene bisacetamide (HMBA) Induced Protein 1 (HEXIM1) as a tumor suppressor whose expression is decreased in breast and prostate cancer. The anti-cancer actions of HEXIM1 in melanomas and AML have been reported by other groups. Previous studies have shown that 5-Aza-2\u2032deoxycytidine (5-AzadC), a DNMT1 inhibitor, induces re-expression of tumor suppressor genes by removing\/erasing methylation marks from their promoters. Our studies highlighted another mechanism wherein 5-AzadC induced DNA damage, which then resulted in enhanced occupancy of NF-\u0138B, P-TEFb, and serine 2 phosphorylated RNA Polymerase II on the <jats:italic>HEXIM1<\/jats:italic> gene. As a consequence, 5-AzadC induced HEXIM1 expression in prostate cancer cell lines and triple negative breast cancers. 5-AzadC-induced DNA damage enhanced P-TEFb occupancy via a mechanism that involved activation of ATR and ATM and induction of NF-\u0138B recruitment to the <jats:italic>HEXIM1<\/jats:italic> promoter. Downregulation of NF-\u0138B attenuated 5-AzadC-induced HEXIM1 expression in prostate and breast cancer cells. The functional relevance of 5-AzadC-induced HEXIM1 expression is revealed by studies showing the HEXIM1 is required for the induction of apoptosis. Collectively, our findings support a non-epigenetic mechanism for 5-AzadC-induced re-expression of HEXIM1 protein, and may contribute to the clinical efficacy of 5-AzadC.<\/jats:p>","DOI":"10.1038\/s41598-020-78058-y","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T11:04:47Z","timestamp":1606993487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Non-epigenetic induction of HEXIM1 by DNMT1 inhibitors and functional relevance"],"prefix":"10.1038","volume":"10","author":[{"given":"Vikas","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica M.","family":"Montano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"78058_CR1","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/jnci\/djj447","volume":"98","author":"GS Mack","year":"2006","unstructured":"Mack, G. S. Epigenetic cancer therapy makes headway. J. Natl. Cancer Inst. 98, 1443\u20131444. https:\/\/doi.org\/10.1093\/jnci\/djj447 (2006).","journal-title":"J. Natl. Cancer Inst."},{"key":"78058_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/a:1011946030404","volume":"15","author":"CM Bender","year":"1998","unstructured":"Bender, C. M., Zingg, J. M. & Jones, P. A. DNA methylation as a target for drug design. Pharm. Res. 15, 175\u2013187. https:\/\/doi.org\/10.1023\/a:1011946030404 (1998).","journal-title":"Pharm. Res."},{"key":"78058_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/978-3-642-81947-6_15","volume":"84","author":"PA Jones","year":"1983","unstructured":"Jones, P. A., Taylor, S. M. & Wilson, V. L. Inhibition of DNA methylation by 5-azacytidine. Recent Results Cancer Res. 84, 202\u2013211. https:\/\/doi.org\/10.1007\/978-3-642-81947-6_15 (1983).","journal-title":"Recent Results Cancer Res."},{"key":"78058_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-3-642-69370-0_8","volume":"108","author":"SM Taylor","year":"1984","unstructured":"Taylor, S. M., Constantinides, P. A. & Jones, P. A. 5-Azacytidine, DNA methylation, and differentiation. Curr. Top. Microbiol. Immunol. 108, 115\u2013127. https:\/\/doi.org\/10.1007\/978-3-642-69370-0_8 (1984).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"78058_CR5","doi-asserted-by":"publisher","first-page":"32260","DOI":"10.1074\/jbc.272.51.32260","volume":"272","author":"AT Ferguson","year":"1997","unstructured":"Ferguson, A. T. et al. Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2\u2019deoxycytidine-induced cytotoxicity in human breast cancer cells. J. Biol. Chem. 272, 32260\u201332266. https:\/\/doi.org\/10.1074\/jbc.272.51.32260 (1997).","journal-title":"J. Biol. Chem."},{"key":"78058_CR6","doi-asserted-by":"publisher","first-page":"11797","DOI":"10.1073\/pnas.91.25.11797","volume":"91","author":"R Juttermann","year":"1994","unstructured":"Juttermann, R., Li, E. & Jaenisch, R. Toxicity of 5-aza-2\u2019-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc. Natl. Acad. Sci. USA 91, 11797\u201311801. https:\/\/doi.org\/10.1073\/pnas.91.25.11797 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"78058_CR7","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1158\/1535-7163.mct-07-0010","volume":"6","author":"T Kiziltepe","year":"2007","unstructured":"Kiziltepe, T. et al. 5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells. Mol. Cancer Ther. 6, 1718\u20131727. https:\/\/doi.org\/10.1158\/1535-7163.mct-07-0010 (2007).","journal-title":"Mol. Cancer Ther."},{"key":"78058_CR8","doi-asserted-by":"publisher","first-page":"8416","DOI":"10.1093\/nar\/gku529","volume":"42","author":"L Fang","year":"2014","unstructured":"Fang, L. et al. ATM regulates NF-kappaB-dependent immediate-early genes via RelA Ser 276 phosphorylation coupled to CDK9 promoter recruitment. Nucl. Acids Res. 42, 8416\u20138432. https:\/\/doi.org\/10.1093\/nar\/gku529 (2014).","journal-title":"Nucl. Acids Res."},{"key":"78058_CR9","doi-asserted-by":"publisher","first-page":"9918","DOI":"10.1074\/jbc.M113.539015","volume":"289","author":"P Liu","year":"2014","unstructured":"Liu, P. et al. Release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein (snRNP) activates hexamethylene bisacetamide-inducible protein (HEXIM1) transcription. J. Biol. Chem. 289, 9918\u20139925. https:\/\/doi.org\/10.1074\/jbc.M113.539015 (2014).","journal-title":"J. Biol. Chem."},{"key":"78058_CR10","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.celrep.2013.11.003","volume":"5","author":"RP McNamara","year":"2013","unstructured":"McNamara, R. P., McCann, J. L., Gudipaty, S. A. & D\u2019Orso, I. Transcription factors mediate the enzymatic disassembly of promoter-bound 7SK snRNP to locally recruit P-TEFb for transcription elongation. Cell Rep. 5, 1256\u20131268. https:\/\/doi.org\/10.1016\/j.celrep.2013.11.003 (2013).","journal-title":"Cell Rep."},{"key":"78058_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1042\/bj20140174","volume":"462","author":"IJ Yeh","year":"2014","unstructured":"Yeh, I. J. et al. HEXIM1 plays a critical role in the inhibition of the androgen receptor by anti-androgens. Biochem. J. 462, 315\u2013327. https:\/\/doi.org\/10.1042\/bj20140174 (2014).","journal-title":"Biochem. J."},{"key":"78058_CR12","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1038\/onc.2011.76","volume":"30","author":"W Ketchart","year":"2011","unstructured":"Ketchart, W. et al. HEXIM1 is a critical determinant of the response to tamoxifen. Oncogene 30, 3563\u20133569. https:\/\/doi.org\/10.1038\/onc.2011.76 (2011).","journal-title":"Oncogene"},{"key":"78058_CR13","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1038\/onc.2012.405","volume":"32","author":"W Ketchart","year":"2013","unstructured":"Ketchart, W. et al. Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis. Oncogene 32, 3829\u20133839. https:\/\/doi.org\/10.1038\/onc.2012.405 (2013).","journal-title":"Oncogene"},{"key":"78058_CR14","doi-asserted-by":"publisher","first-page":"36443","DOI":"10.1074\/jbc.M112.374157","volume":"287","author":"QJ Lew","year":"2012","unstructured":"Lew, Q. J. et al. Identification of HEXIM1 as a positive regulator of p53. J. Biol. Chem. 287, 36443\u201336454. https:\/\/doi.org\/10.1074\/jbc.M112.374157 (2012).","journal-title":"J. Biol. Chem."},{"key":"78058_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mce.2016.04.024","volume":"431","author":"V Sharma","year":"2016","unstructured":"Sharma, V. et al. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin. Mol. Cell. Endocrinol. 431, 12\u201323. https:\/\/doi.org\/10.1016\/j.mce.2016.04.024 (2016).","journal-title":"Mol. Cell. Endocrinol."},{"key":"78058_CR16","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/mc.22433","volume":"55","author":"V Sharma","year":"2016","unstructured":"Sharma, V. et al. Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re-expressing the epigenetically repressed tumor suppressor-estrogen receptor beta. Mol. Carcinog. 55, 1843\u20131857. https:\/\/doi.org\/10.1002\/mc.22433 (2016).","journal-title":"Mol. Carcinog."},{"key":"78058_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2016.05.029","volume":"379","author":"W Ketchart","year":"2016","unstructured":"Ketchart, W. et al. Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism. Cancer Lett. 379, 60\u201369. https:\/\/doi.org\/10.1016\/j.canlet.2016.05.029 (2016).","journal-title":"Cancer Lett."},{"key":"78058_CR18","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s12041-016-0729-8","volume":"95","author":"D Sun","year":"2016","unstructured":"Sun, D., Yu, Q., Li, P. & Shen, J. Genomewide analyses of pathogenic and regulatory T cells of NOD mice reveal a significant difference in DNA methylation on chromosome X. J. Genet. 95, 1023\u20131029. https:\/\/doi.org\/10.1007\/s12041-016-0729-8 (2016).","journal-title":"J. Genet."},{"key":"78058_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.molcel.2016.03.013","volume":"62","author":"JL Tan","year":"2016","unstructured":"Tan, J. L. et al. Stress from nucleotide depletion activates the transcriptional regulator HEXIM1 to suppress melanoma. Mol. Cell 62, 34\u201346. https:\/\/doi.org\/10.1016\/j.molcel.2016.03.013 (2016).","journal-title":"Mol. Cell"},{"key":"78058_CR20","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1038\/cddis.2012.181","volume":"3","author":"E Fokas","year":"2012","unstructured":"Fokas, E. et al. Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation. Cell Death Disease 3, e441. https:\/\/doi.org\/10.1038\/cddis.2012.181 (2012).","journal-title":"Cell Death Disease"},{"key":"78058_CR21","first-page":"4375","volume":"59","author":"JN Sarkaria","year":"1999","unstructured":"Sarkaria, J. N. et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Can. Res. 59, 4375\u20134382 (1999).","journal-title":"Can. Res."},{"key":"78058_CR22","doi-asserted-by":"publisher","first-page":"7527","DOI":"10.1093\/nar\/gkw585","volume":"44","author":"CQ Aj","year":"2016","unstructured":"Aj, C. Q., Bugai, A. & Barboric, M. Cracking the control of RNA polymerase II elongation by 7SK snRNP and P-TEFb. Nucl. Acids Res. 44, 7527\u20137539. https:\/\/doi.org\/10.1093\/nar\/gkw585 (2016).","journal-title":"Nucl. Acids Res."},{"key":"78058_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/s1097-2765(01)00314-8","volume":"8","author":"M Barboric","year":"2001","unstructured":"Barboric, M., Nissen, R. M., Kanazawa, S., Jabrane-Ferrat, N. & Peterlin, B. M. NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 8, 327\u2013337. https:\/\/doi.org\/10.1016\/s1097-2765(01)00314-8 (2001).","journal-title":"Mol. Cell"},{"key":"78058_CR24","doi-asserted-by":"publisher","first-page":"10191","DOI":"10.1038\/ncomms10191","volume":"6","author":"H Bunch","year":"2015","unstructured":"Bunch, H. et al. Transcriptional elongation requires DNA break-induced signalling. Nat. Commun. 6, 10191. https:\/\/doi.org\/10.1038\/ncomms10191 (2015).","journal-title":"Nat. Commun."},{"key":"78058_CR25","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1074\/jbc.M114.605816","volume":"290","author":"K Fujinaga","year":"2015","unstructured":"Fujinaga, K., Luo, Z., Schaufele, F. & Peterlin, B. M. Visualization of positive transcription elongation factor b (P-TEFb) activation in living cells. J. Biol. Chem. 290, 1829\u20131836. https:\/\/doi.org\/10.1074\/jbc.M114.605816 (2015).","journal-title":"J. Biol. Chem."},{"key":"78058_CR26","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1128\/mcb.00226-15","volume":"35","author":"SA Gudipaty","year":"2015","unstructured":"Gudipaty, S. A., McNamara, R. P., Morton, E. L. & D\u2019Orso, I. PPM1G binds 7SK RNA and Hexim1 to block P-TEFb assembly into the 7SK snRNP and sustain transcription elongation. Mol. Cell Biol. 35, 3810\u20133828. https:\/\/doi.org\/10.1128\/mcb.00226-15 (2015).","journal-title":"Mol. Cell Biol."},{"key":"78058_CR27","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/cancers5030838","volume":"5","author":"QJ Lew","year":"2013","unstructured":"Lew, Q. J., Chu, K. L., Chia, Y. L., Cheong, N. & Chao, S. H. HEXIM1, a new player in the p53 pathway. Cancers (Basel) 5, 838\u2013856. https:\/\/doi.org\/10.3390\/cancers5030838 (2013).","journal-title":"Cancers (Basel)"},{"key":"78058_CR28","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1038\/onc.2010.110","volume":"29","author":"N Ogba","year":"2010","unstructured":"Ogba, N. et al. HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland. Oncogene 29, 3639\u20133649 (2010).","journal-title":"Oncogene"},{"key":"78058_CR29","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1038\/sj.onc.1208728","volume":"24","author":"BM Wittmann","year":"2005","unstructured":"Wittmann, B. M., Fujinaga, K., Deng, H., Ogba, N. & Montano, M. M. The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1. Oncogene 24, 5576\u20135588 (2005).","journal-title":"Oncogene"},{"key":"78058_CR30","first-page":"5151","volume":"63","author":"BM Wittmann","year":"2003","unstructured":"Wittmann, B. M., Wang, N. & Montano, M. M. Identification of a novel inhibitor of cell growth that is down-regulated by estrogens and decreased in breast tumors. Cancer Res. 63, 5151\u20135158 (2003).","journal-title":"Cancer Res."},{"key":"78058_CR31","first-page":"5310","volume":"58","author":"DF Jarrard","year":"1998","unstructured":"Jarrard, D. F. et al. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Cancer Res. 58, 5310\u20135314 (1998).","journal-title":"Cancer Res."},{"key":"78058_CR32","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1038\/labinvest.3780190","volume":"80","author":"T Nakayama","year":"2000","unstructured":"Nakayama, T. et al. Epigenetic regulation of androgen receptor gene expression in human prostate cancers. Lab. Invest. 80, 1789\u20131796 (2000).","journal-title":"Lab. Invest."},{"key":"78058_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13058-019-1228-7","volume":"21","author":"MM Montano","year":"2019","unstructured":"Montano, M. M. et al. Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells. Breast Cancer Res.: BCR 21, 138. https:\/\/doi.org\/10.1186\/s13058-019-1228-7 (2019).","journal-title":"Breast Cancer Res.: BCR"},{"key":"78058_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.20517\/2394-4722.2017.03","volume":"3","author":"W Wang","year":"2017","unstructured":"Wang, W., Mani, A. M. & Wu, Z. H. DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression. J. Cancer Metastasis Treat. 3, 45\u201359. https:\/\/doi.org\/10.20517\/2394-4722.2017.03 (2017).","journal-title":"J. Cancer Metastasis Treat."},{"key":"78058_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.tcb.2003.12.004","volume":"14","author":"ND Perkins","year":"2004","unstructured":"Perkins, N. D. NF-kappaB: tumor promoter or suppressor?. Trends Cell Biol. 14, 64\u201369. https:\/\/doi.org\/10.1016\/j.tcb.2003.12.004 (2004).","journal-title":"Trends Cell Biol."},{"key":"78058_CR36","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2147\/ott.S161109","volume":"11","author":"L Xia","year":"2018","unstructured":"Xia, L. et al. Role of the NFkappaB-signaling pathway in cancer. Oncol. Targets Therapy 11, 2063\u20132073. https:\/\/doi.org\/10.2147\/ott.S161109 (2018).","journal-title":"Oncol. Targets Therapy"},{"key":"78058_CR37","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.cell.2018.06.039","volume":"174","author":"DA Quigley","year":"2018","unstructured":"Quigley, D. A. et al. Genomic hallmarks and structural variation in metastatic prostate cancer. Cell 174, 758-769.e759. https:\/\/doi.org\/10.1016\/j.cell.2018.06.039 (2018).","journal-title":"Cell"},{"key":"78058_CR38","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson, D. et al. Integrative clinical genomics of advanced prostate cancer. Cell 161, 1215\u20131228. https:\/\/doi.org\/10.1016\/j.cell.2015.05.001 (2015).","journal-title":"Cell"},{"key":"78058_CR39","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature10933","volume":"486","author":"SP Shah","year":"2012","unstructured":"Shah, S. P. et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486, 395\u2013399. https:\/\/doi.org\/10.1038\/nature10933 (2012).","journal-title":"Nature"},{"key":"78058_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.molonc.2010.04.006","volume":"4","author":"F Podo","year":"2010","unstructured":"Podo, F. et al. Triple-negative breast cancer: present challenges and new perspectives. Mol. Oncol. 4, 209\u2013229. https:\/\/doi.org\/10.1016\/j.molonc.2010.04.006 (2010).","journal-title":"Mol. Oncol."},{"key":"78058_CR41","doi-asserted-by":"publisher","first-page":"232870","DOI":"10.1155\/2014\/232870","volume":"2014","author":"R Chen","year":"2014","unstructured":"Chen, R., Yik, J. H., Lew, Q. J. & Chao, S. H. Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer. Biomed. Res. Int. 2014, 232870. https:\/\/doi.org\/10.1155\/2014\/232870 (2014).","journal-title":"Biomed. Res. Int."},{"key":"78058_CR42","first-page":"5151","volume":"63","author":"BM Wittmann","year":"2003","unstructured":"Wittmann, B. M., Wang, N. & Montano, M. M. Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumors. Cancer Res. 63, 5151\u20135158 (2003).","journal-title":"Cancer Res."},{"key":"78058_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1042\/bj20130592","volume":"456","author":"IJ Yeh","year":"2013","unstructured":"Yeh, I. J., Ogba, N., Bensigner, H., Welford, S. M. & Montano, M. M. HEXIM1 down-regulates hypoxia-inducible factor-1alpha protein stability. Biochem. J. 456, 195\u2013204. https:\/\/doi.org\/10.1042\/bj20130592 (2013).","journal-title":"Biochem. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78058-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78058-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78058-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:11:30Z","timestamp":1670371890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78058-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["78058"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78058-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2020,12,3]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21015"}}